Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.340
-0.010 (-0.74%)
At close: Jan 31, 2025, 4:00 PM
1.320
-0.020 (-1.49%)
After-hours: Jan 31, 2025, 6:00 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $59.71 million as of January 31, 2025. Its market cap has decreased by -64.97% in one year.
Market Cap
59.71M
Enterprise Value
-26.33M
1-Year Change
-64.97%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $59.71M, a decrease of -86.44%. That is a compound annual growth rate of -41.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 59.71M | -9.46% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |